DeSalvo Karen B

SEC source: 0001193125-26-083018 · ownership.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,369.59

F1 · date: These shares represent deferred stock units that were granted without cash consideration on February 26, 2026 under the Amended and Restated Welltower Inc. 2022 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on February 26, 2027.

F1 · shares: These shares represent deferred stock units that were granted without cash consideration on February 26, 2026 under the Amended and Restated Welltower Inc. 2022 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on February 26, 2027.

SEC source: 0000950170-25-031008 · ownership.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,313.59

F1 · date: These shares represent deferred stock units that were granted without cash consideration on February 28, 2025 under the Welltower Inc. 2022 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on February 28, 2026.

F1 · shares: These shares represent deferred stock units that were granted without cash consideration on February 28, 2025 under the Welltower Inc. 2022 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on February 28, 2026.

SEC source: 0000950170-25-036506 · ownership.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,313.59

F1 · date: These shares represent deferred stock units that were granted without cash consideration on February 28, 2025 under the Welltower Inc. 2022 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on February 28, 2026. The amount of securities beneficially owned following the reported transaction was incorrectly reported.

F1 · shares: These shares represent deferred stock units that were granted without cash consideration on February 28, 2025 under the Welltower Inc. 2022 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on February 28, 2026. The amount of securities beneficially owned following the reported transaction was incorrectly reported.

SEC source: 0000950170-25-061979 · ownership.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,313.59

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.35 to $151.50, inclusive. The reporting person undertakes to provide to Welltower Inc. (the "Company"), any security holder of the Company or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0000950170-24-029367 · ownership.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,879.59

F1 · shares: These shares represent dividend equivalent rights accrued on the reporting person's deferred stock units, which may only be settled in common stock.

SEC source: 0000950170-24-025270 · ownership.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,846.59

F1 · date: These shares represent deferred stock units that were granted without cash consideration on March 1, 2024 under the Welltower Inc. 2022 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on March 1, 2025.

F1 · shares: These shares represent deferred stock units that were granted without cash consideration on March 1, 2024 under the Welltower Inc. 2022 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on March 1, 2025.

SEC source: 0001209191-23-056701 · doc4.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,689.59

F1 · shares: These shares represent dividend equivalent rights accrued on the reporting person's deferred stock units, which may only be settled in common stock.

SEC source: 0001209191-23-047364 · doc4.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,609.59

F1 · shares: These shares represent dividend equivalent rights accrued on the reporting person's deferred stock units, which may only be settled in common stock.

SEC source: 0001209191-23-032171 · doc4.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,588.59

F1 · shares: These shares represent dividend equivalent rights accrued on the reporting person's deferred stock units, which may only be settled in common stock.

SEC source: 0001209191-23-017829 · doc4.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,552.59

F1 · shares: These shares represent dividend equivalent rights accrued on the reporting person's deferred stock units, which may only be settled in common stock.

SEC source: 0001209191-23-013204 · doc4.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,458.06

F1 · shares: These shares represent deferred stock units that were granted without cash consideration on February 23, 2023 under the Welltower Inc. 2022 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on February 23, 2024.

F1 · price: These shares represent deferred stock units that were granted without cash consideration on February 23, 2023 under the Welltower Inc. 2022 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on February 23, 2024.

SEC source: 0001209191-22-059719 · doc4.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,831.06

F1 · shares: These shares represent dividend equivalent rights accrued on the reporting person's deferred stock units, which become exercisable proportionately with the deferred stock units to which they relate and may only be settled in common stock. Each dividend equivalent right represents a right to receive one share of common stock of Welltower Inc. at the time of vesting.

SEC source: 0001209191-22-048240 · doc4.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,813.45

F1 · shares: These shares represent dividend equivalent rights accrued on the reporting person's deferred stock units, which become exercisable proportionately with the deferred stock units to which they relate and may only be settled in common stock. Each dividend equivalent right represents a right to receive one share of common stock of Welltower Inc. at the time of vesting.

SEC source: 0001209191-22-033171 · doc4.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,797.14

F1 · shares: These shares represent dividend equivalent rights accrued on the reporting person's deferred stock units, which become exercisable proportionately with the deferred stock units to which they relate and may only be settled in common stock. Each dividend equivalent right represents a right to receive one share of common stock of Welltower Inc. at the time of vesting.

SEC source: 0001209191-22-016687 · doc4.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,783

F1 · shares: These shares represent deferred stock units that were granted without cash consideration on March 3, 2022 under the Welltower Inc. 2016 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on March 3, 2023.

F1 · price: These shares represent deferred stock units that were granted without cash consideration on March 3, 2022 under the Welltower Inc. 2016 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on March 3, 2023.

SEC source: 0001209191-21-036264 · doc4.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,733

F1 · shares: These shares represent deferred stock units that were granted without cash consideration on May 26, 2021 under the Welltower Inc. 2016 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on February 12, 2022.

F1 · price: These shares represent deferred stock units that were granted without cash consideration on May 26, 2021 under the Welltower Inc. 2016 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on February 12, 2022.

SEC source: 0001209191-21-010832 · doc4.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,532

F1 · shares: These shares represent deferred stock units that were granted without cash consideration on February 12, 2021 under the Welltower Inc. 2016 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on the first anniversary of the grant date.

F1 · price: These shares represent deferred stock units that were granted without cash consideration on February 12, 2021 under the Welltower Inc. 2016 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on the first anniversary of the grant date.

SEC source: 0001209191-20-008019 · doc4.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,161

F1 · shares: These shares represent deferred stock units that were granted without cash consideration on February 6, 2020 under the Welltower Inc. 2016 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on the first anniversary of the grant date.

F1 · price: These shares represent deferred stock units that were granted without cash consideration on February 6, 2020 under the Welltower Inc. 2016 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on the first anniversary of the grant date.

SEC source: 0001209191-19-009032 · doc4.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,271

F1 · shares: These shares represent deferred stock units that were granted without cash consideration on February 7, 2019 under the Welltower Inc. 2016 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on the first anniversary of the grant date.

F1 · price: These shares represent deferred stock units that were granted without cash consideration on February 7, 2019 under the Welltower Inc. 2016 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on the first anniversary of the grant date.

SEC source: 0000049071-19-000006 · edgar.xml · derivative · entry 4

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 588

Underlying: Humana Common · 588 shares

Expires not disclosed

F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/19.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/19.

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/19.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/19.

SEC source: 0000049071-19-000006 · edgar.xml · derivative · entry 3

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4

Underlying: Humana Common · 4 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

SEC source: 0001209191-18-060930 · doc4.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194

F1 · shares: These shares represent deferred stock units that were granted without cash consideration on November 30, 2018 under the Welltower Inc. 2016 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on the first anniversary of the grant date.

F1 · price: These shares represent deferred stock units that were granted without cash consideration on November 30, 2018 under the Welltower Inc. 2016 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on the first anniversary of the grant date.

SEC source: 0000049071-18-000128 · edgar.xml · derivative · entry 2

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 634 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · derivative.exercise_date: Initial award of $155,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 11/10/2018 and forfeited in its entirety if service is less than one year.

F2 · derivative.expiration_date: Initial award of $155,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 11/10/2018 and forfeited in its entirety if service is less than one year.

SEC source: 0000049071-18-000128 · edgar.xml · nonDerivative · entry 1

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 634

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000049071-18-000002 · edgar.xml · derivative · entry 3

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 658

Underlying: Humana Common · 658 shares

Expires not disclosed

F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/18.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/18.

SEC source: 0000049071-17-000171 · edgar.xml · derivative · entry 2

DeSalvo Karen B · CIK 0001722342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 634

Underlying: Humana Common · 634 shares

Expires not disclosed

F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · derivative.exercise_date: Initial award of $155,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 11/10/2018 and forfeited in its entirety if service is less than one year.

F2 · derivative.expiration_date: Initial award of $155,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 11/10/2018 and forfeited in its entirety if service is less than one year.